Put This Small Cap Stock On Radar! Amyris Inc (NASDAQ:AMRS)

Screen Shot 2016-07-09 at 11.08.59 AM

Symbol: AMRS
Company: Amyris, Inc.
Quote: http://finance.yahoo.com/q?s=AMRS
Latest News: http://finance.yahoo.com/q/h?s=AMRS+Headlines
Company Website: http://www.amyris.com

New Trade Alert: Amyris Inc (NASDAQ:AMRS)

AMRS is a self-styled global renewable products company providing sustainable alternatives to a variety of non-renewable resources. Basically, they convert plant-based simple carbs into hydrocarbons (petroleum alternatives).

The output goes to a range of customers B2B, including food processors, fragrance makers, cosmetics companies, as well as to the specialty fluids, polymers, lubricants, and fuels industries.

On a more general note, the company has a special ability to generate diverse compounds, which recently resulted in their announcement of a plan to “launch its uPharm(TM) (microPharm) Discovery and Production Platform. Amyris’s uPharm platform provides the pharmaceutical industry with an integrated discovery and production process for therapeutic compounds for which a natural source is scarce or unavailable, or for which chemical synthesis is not cost-effective.”

Just ahead of that, the company announced its plan to move into the industrial cleaning products market (see full release). That puts this company in about 6 major industries. We like that… a lot. It suggests diverse monetization opportunities as a base case.

We also love the chart here. This is mostly a technical play, in fact, because it hit a screen of ours that often generates massive winners for us.

The stock is coming off a base RSI of 25 at the pivot a few days ago, and we just got the MACD bullish crossover. This major pivot is happening right off a new 52week low  of at .31cent

The last two alerts we put out that had similar characteristics netted traders as much as an average of 60% in one-day gains.

About AMRS

AMRS (Amyris, Inc.) a renewable products company, provides various alternatives to a range of petroleum-sourced products for the specialty chemical and transportation fuel markets worldwide.

AMRS builds and applies its industrial synthetic biology platform to design microbes, primarily yeast, to convert plant-sourced sugars into renewable hydrocarbons.

AMRS produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products. It also provides Biofene for specialty chemical applications and transportation fuels, such as diesel. In addition, the company is involved in the development, production, and commercialization of renewable base oils, as well as additives and lubricants for the automotive, industrial, and commercial lubricants markets; and offers natural oils and aroma chemicals for the flavors and fragrances market..

AMRS was founded in 2003 and is headquartered in Emeryville, California.

What You Need To Know:


Falling to a new 52-week low is never fun for company’s shareholder, but, depending on who you ask, it can be either a buy or a sell signal. Someone bearish on the stock might see it reaching its lowest price in a year as a sign of growing downward momentum and make sure they sell their shares. Bulls, though, are more likely to see a new 52-week low as the stock hitting its low point and anticipate a bounce in the share price.

03/10/2016 – Amyris, Inc. had its “market perform” rating reiterated by analysts at Cowen. They now have a USD 2 price target on the stock.

11/10/2015 – Rodman & Renshaw began new coverage on Amyris, Inc. giving the company a “buy” rating. They now have a USD 4 price target on the stock.

The company generates $87,000 in revenue per employee which is below the sector average of $5.6 million.

Amyris, Inc. generates $0.25 in revenue for every $1 in expense, which is extremely poor and substantially below the sector average of $1.64. A year ago Operating Revenues/Operating Expense was 0.24. In the last year we can see operating margins are increasing but are still less than 1.0, which the minimum level needed to turn an operating profit.

AMRS’s fundamental rating was affected from the operating margin numbers in the following ways:
1. The current value is below the critical 1.0 level so the firm generates an operating loss.
2. The one-year change was positive which raises the rating a little.

Total Views: 3186 ,